BP005638: Biotinylated Human TRAIL R2/DR5/TNFRSF10B Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human TRAIL R2/DR5/TNFRSF10B Protein, (amino acids Ile56-Glu182) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human TRAIL R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-TRAIL R2 Antibody protein with the C-hFc tag with the EC50 of 5.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003625: Cynomolgus TRAIL R2/DR5/TNFRSF10B Protein with the C-His Tag
Source: The recombinant Cynomolgus TRAIL R2/DR5/TNFRSF10B Protein, (amino acids Ile58-Ser212) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus TRAIL R2 protein with the C-His tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-TRAIL R2 Antibody protein with the C-hFc tag with the EC50 of 3.9 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004305: Human TRAIL R2/DR5/TNFRSF10B Protein with the C-hFc Tag
Source: The recombinant Human TRAIL R2/DR5/TNFRSF10B Protein, (amino acids Ile56-Glu182) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human Trail protein with the C-hFc tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human TRAIL R2 protein with the C-hFc tag with the EC50 of 4.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005541: Human TRAIL R2/DR5/TNFRSF10B Protein with the C-His-Avi Tag
Source: The recombinant Human TRAIL R2/DR5/TNFRSF10B Protein, (amino acids Ile56-Glu182) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human TRAIL R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-TRAIL R2 Antibody protein with the C-hFc tag with the EC50 of 8.5 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004602: Mouse TRAIL R2/DR5/TNFRSF10B Protein with the C-His Tag
Source: The recombinant Mouse TRAIL R2/DR5/TNFRSF10B Protein, (amino acids Asn53-Lys180) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: The affinity constant of 0.43 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP002458-C326: Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) Protein
Source: HEK 293-derived.
Purity: > 95.0% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP002458-CYT-069: Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) Protein
Source: E. coli-derived.
The TNFRSF10B reduced the production of LPS-induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/mL) but in the presence of TNFRSF10B, TRAIL-induced TNF is suppressed.
Purity: > 95.0% by SDS-PAGE.